Faucetworks is a Delaware-incorporated limited liability company founded in 2018 and headquartered in Emeryville, California.
Faucetworks is led by:
Dr. Borsody is a stroke neurologist and serial medical device entrepreneur who has served as medical director for major pharmaceutical stroke programs including AstraZeneca's NXY059, Lundbeck's desmoteplase, and Genentech's Activase (rtPA).
Ms. Barreto is a Jurisprudence and Social Policy Ph.D. candidate at the University of California – Berkeley School of Law graduate whose focus is on medical uses for artificial intelligence. She is a Eugene-Cota Robles Fellowship awardee and Fellow of the American Political Science Association.
Ms. Montenegro is an experienced product development manager who has 13 years managing information technology and computer services for major European and Latin American corporations. She has a Masters degree in electrical engineering at Sonoma State University.
Faucetworks collaborates with NeuroSpring, a 501(c)(3) public charity that supports neuroscience research, to obtain unbiased medical and scientific input on the Faucet AID.
Dr. Hasegawa-Johnson is a Professor of Electrical and Computer Engineering at the University of Illinois – Urbana’s Beckman Institute for Advanced Science and Technology. He is a world-recognized authority in computer recognition of human speech and speech pathology, with specific experience in the use of artificial intelligence-based processes for medical uses.
Dr. Abedi is a Research Scientist at the Biomedical & Tanslational Informatics Division of the Geisinger Health System. A former faculty member of the University of Memphis and Virginia Tech, Dr. Abedi is a pioneer in the use of artificial intelligence to evaluate neurological patients. Dr. Abedi supports the design and training of the Faucet's computational algorithms.
Dr. Gorelick is Chairman of the Department of Neurology and Director of Stroke Research at the University of Illinois – Chicago. He has served in leadership roles for numerous clinical treatment trials and has received the National Stroke Association’s Visionary in Stroke award.
Dr. Grotta is Director of the Mobile Stroke Unit Consortium of the Texas Medical Center. He has played a leadership role in many clinical research treatment trials examining neurologic emergencies. NIH presently funds his research into pre-hospital treatment of stroke in ambulances.
Dr. Jauch is former Chair of the Department of Emergency Medicine at the Medical University of South Carolina and current Chief of System Research at Mission Health. In addition to being a practicing emergency medicine physician, he is an Adjunct Professor in Biomedical Engineering at Clemson.
Dr. Saver is a Professor of Neurology at the University of California - Los Angeles and Director of the Stroke and Vascular Neurology Program. He organized and directed the FAST-MAG clinical trial, one of the largest ambulance-based clinical trials testing the effectiveness of a novel emergency treatment for stroke.